» Articles » PMID: 36400464

Chronic Hepatitis B Virus and Hepatitis D Virus: New Developments

Overview
Journal Clin Liver Dis
Specialty Gastroenterology
Date 2022 Nov 18
PMID 36400464
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis B virus (HBV) and hepatitis D virus are leading causes of morbidity and mortality worldwide. Despite the availability of HBV vaccinations that are 98% to 100% effective, an estimated 820,000 annual deaths were attributed to HBV in 2019, mainly related to the sequelae of cirrhosis and hepatocellular carcinoma. Because disease prevalence is concentrated outside of the United States, it is overlooked, but with expanded vaccination recommendations provided by the Centers for Disease Control and Prevention and recommended screening, as well as heightened awareness by health care providers, we can work toward the eradication of this preventable disease.

Citing Articles

Enhancing liver fibrosis detection: a novel PIGR-utilizing approach in chronic hepatitis B injury assessment.

Chu S, Chen Y, Wang Y BMC Gastroenterol. 2025; 25(1):82.

PMID: 39955486 PMC: 11830201. DOI: 10.1186/s12876-025-03672-x.


Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives.

Yang S, Zou Y, Zhong C, Zhou Z, Peng X, Tang C Front Cell Dev Biol. 2025; 13:1522206.

PMID: 39917567 PMC: 11798966. DOI: 10.3389/fcell.2025.1522206.


Clinical effectiveness of entecavir versus tenofovir disoproxil fumarate tablets in chronic hepatitis B treatment.

Zhou Y, Shen Y, He J, Yang X Am J Transl Res. 2025; 16(12):7591-7599.

PMID: 39822557 PMC: 11733369. DOI: 10.62347/RKNH8649.


The role of inflammasome in chronic viral hepatitis.

Wan P, Yang G, Cheng Q, Zhang X, Yue Z, Li M Front Cell Infect Microbiol. 2024; 14:1382029.

PMID: 38817443 PMC: 11137247. DOI: 10.3389/fcimb.2024.1382029.


Delta Hepatitis in the United States: Epidemiology, Testing, and Linkage to Care.

Gish R Gastroenterol Hepatol (N Y). 2024; 19(10):603-605.

PMID: 38404959 PMC: 10882855.